|
FRMD4B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.98969951625827E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.28289999734577E-08 |
| Normal-vs-Stage2 |
2.665900E-02 |
| Normal-vs-Stage3 |
1.651450E-01 |
| Normal-vs-Stage4 |
9.260200E-01 |
| Stage1-vs-Stage2 |
7.340000E-01 |
| Stage1-vs-Stage3 |
8.294300E-02 |
| Stage1-vs-Stage4 |
3.84880000000587E-05 |
| Stage2-vs-Stage3 |
3.398600E-01 |
| Stage2-vs-Stage4 |
3.548300E-02 |
| Stage3-vs-Stage4 |
2.097800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.70700003815961E-09 |
| Normal-vs-AfricanAmerican |
1.8977899999939E-05 |
| Normal-vs-Asian |
7.418800E-01 |
| Caucasian-vs-AfricanAmerican |
5.667200E-01 |
| Caucasian-vs-Asian |
2.881000E-01 |
| AfricanAmerican-vs-Asian |
2.247600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.4650995668103E-10 |
| Normal-vs-Female |
3.61060000000357E-05 |
| Male-vs-Female |
6.854000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.238000E-02 |
| Normal-vs-Extreme_Weight |
3.58070000000543E-05 |
| Normal-vs-Obese |
3.54909999999986E-06 |
| Normal-vs-Extreme_Obese |
1.187950E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.836000E-01 |
| Normal_Weight-vs-Obese |
9.461600E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.267400E-01 |
| Extreme_Weight-vs-Obese |
4.557000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.909400E-01 |
| Obese-vs-Extreme_Obese |
4.372000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.163700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.21470000724599E-09 |
| Normal-vs-Age(61-80Yrs) |
4.02690000000927E-06 |
| Normal-vs-Age(81-100Yrs) |
9.279300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.083500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.846000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.634800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.386300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.194400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.650200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62547753035369E-12 |
| Normal-VS-Type2 PRCC |
1.495820E-01 |
| Normal-VS-KIRP CIMP |
9.227400E-01 |
| Normal-VS-Unclassified PRCC |
1.004330E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.19689999525485E-09 |
| Type1 PRCC-VS-KIRP CIMP |
2.13159999984391E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.210850E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.784200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.376400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.612280E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.372420E-02 |
| Normal-vs-N1 |
1.063750E-01 |
| Normal-vs-N2 |
2.133800E-01 |
| N0-vs-N1 |
4.680600E-01 |
| N0-vs-N2 |
1.918360E-01 |
| N1-vs-N2 |
1.504200E-01 |
|
|
